Molecular pathogenesis of hepatitis C virus-associated hepatocellular carcinoma

Frontiers in Bioscience

Volumn 12, Issue 1, 2007, Pages 222-233

  Jin, Dong Yan ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Genome instability; HCC; HCV; Hepatic fibrosis; Hepatic steatosis; Hepatitis C virus; Hepatocellular carcinoma; Review; Virus host interaction

Indexed keywords

HEPATITIS C VIRUS;

EID: 34249819367     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2060     Document Type: Article

References (107)

1. Liang T.J. & T. Heller: Pathogenesis of hepatitis C-associated hepatocellular carcinoma. Gastroenterology 127, S62-71 (2004)
2. Shepard C.W., L. Finelli & M.J. Alter: Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5, 558-567 (2005)
3. Giannini C. & C. Brechet: Hepatitis C virus biology. Cell Death Differ 10, S27-S38 (2003)
4. Wang H.-L. & D.-Y. Jin: Prevalence and genotype of hepatitis G virus in Chinese professional blood donors and hepatitis patients. J Inf Dis 175, 1229-1233 (1997)
5. Houghton M. & S. Abrignani: Prospects for a vaccine against the hepatitis C virus. Nature 436, 961-966 (2005)
6. Feld J.J. & J.H. Hoofnagle: Mechanism of actin of interferon and ribavirin in treatment of hepatitis C. Nature 436, 967-972 (2005)
7. Wakita T., T. Pietschmann, T. Kato, T. Date, M. Miyamoto, Z. Zhao, K. Murthy, A. Habermann, H.G. Krausslich, M. Mizokami, R. Bartenschlager & T.J. Liang: Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11, 791-796 (2005)
8. Heller T., S. Saito, J. Auerbach, T. Williams, T.R. Moreen, A. Jazwinski, B. Cruz, N. Jeurkar, R. Sapp, G. Luo & T.J. Liang: An in vitro model of hepatitis C virion production. Proc Natl Acad Sci USA 102, 2579-2583 (2005)
9. Lindenbach B.D., M.J. Evans, A.J. Syder, B. Wolk, T.L. Tellinghuisen, C.C. Liu, T. Maruyama, R.O. Hynes, D.R. Burton, J.A. McKeating & C.M. Rice: Complete replication of hepatitis C virus in cell culture. Science 309, 623-626 (2005)
10. Zhong J., P. Gastaminza, G. Cheng, S. Kapadia, T. Kato, D.R. Burton, S.F. Wieland, S.L. Uprichard, T. Wakita & F.V. Chisari: Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 102, 9294-9299 (2005)
11. Cai Z., C. Zhang, K.S. Chang, J. Jiang, B.C. Ahn, T. Wakita, T.J. Liang & G. Luo: Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells. J Virol 79, 13963-13973 (2005)
12. Lindenbach B.D. & C.M. Rice: Unravelling hepatitis C virus replication from genome to function. Nature 436, 933-938 (2005)
13. Voisset C. & J. Dubuisson: Functional hepatitis C virus envelope glycoproteins. Biol Cell 96, 413-420 (2004)
14. Pavlovic D., D.C. Neville, O. Argaud, B. Blumberg, R.A. Dwek, W.B. Fischer & N. Zitzmann: The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives. Proc Natl Acad Sci USA 100, 6104-6108 (2003)
15. Griffin S.D., R. Harvey, D.S. Clarke, W.S. Barclay, M. Harris & D.J. Rowlands: A conserved basic loop in hepatitis C virus p7 protein is required for amantadinesensitive ion-channel activity in mammalian cells but is dispensable for localization to mitochondria. J Gen Virol 85, 451-461 (2004)
16. Sakai A., M.S. Claire, K. Faulk, S. Govindarajan, S.U. Emerson, R.H. Purcell & J. Bukh: The p7 polypeptide of hepatitis C virus is critical for infectivity and contains functionally important genotype-specific sequences. Proc Natl Acad Sci USA 100, 11646-11651 (2003)
17. Bartenschlager R.: The NS3/4A proteinase of the hepatitis C virus: unravelling structure and function of an unusual enzyme and a prime target for antiviral therapy. J Viral Hepat 6, 165-181 (1999)
18. Macdonald A. & M. Harris: Hepatitis C virus NS5A: tales of a promiscuous protein. J Gen Virol 85, 2485-502 (2004)
19. Lohmann V., A. Roos, F. Korner, J.O. Koch & R. Bartenschlager: Biochemical and structural analysis of the NS5B RNA-dependent RNA polymerase of the hepatitis C virus. J Viral Hepat 7, 167-174 (2000)
20. Xu Z., J.T. Choi, T.S. Yen, W. Lu, A. Strohecker, S. Govindrajan, D. Chien, M. Selby & J.-h. Ou: Synthesis of a novel hepatitis C virus protein by ribosomal frameshift. EMBO J 20, 3840-3848 (2001)
21. Walewski J.L., T.R. Keller, D.D. Stump & A.D. Branch: Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame. RNA 7, 710-721 (2001)
22. Xu Z., J. Choi, W. Lu & J.-h. Ou: Hepatitis C virus F protein is a short-lived protein associated with the endoplasmic reticulum. J Virol 77, 1578-1583 (2002)
23. Moradpour D., V. Brass, E. Bieck, P. Friebe, R. Gosert, H.E. Blum, R. Bartenschlager, F. Penin & V. Lohmann: Membrane association of the RNA-dependent RNA polymerase is essential for hepatitis C virus RNA replication. J Virol 78, 13278-13284 (2004)
24. Svitkin Y.V., A. Pause, M. Lopez-Lastra, S. Perreault & N. Sonenberg: Complete translation of the hepatitis C virus genome in vitro: Membranes play a critical role in the maturation of all virus proteins except for NS3. J Virol 79, 6868-6881 (2005)
25. Pileri P., Y. Uematsu, S. Campagnoli, G. Galli, F. Falugi, R. Petracca, A.J. Weiner, M. Houghton, D. Rosa, G. Grandi & S. Abrignani: Binding of hepatitis C virus to CD81. Science 282, 938-941 (1998)
26. Cormier E.G., F. Tsamis, F. Kajumo, R.J. Durso, J.P. Gardner & T. Dragic: CD81 is an entry coreceptor for hepatitis C virus. Proc Natl Acad Sci USA 101:7270-7274 (2004)
27. Lavillette D., A.W. Tarr, C. Voisset, P. Donot, B. Bartosch, C. Bain, A.H. Patel, J. Dubuisson, J.K. Ball & F.L. Cosset: Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus. Hepatology 41, 265-274 (2005)
28. Soldaini E., A. Wack, U. D'Oro, S. Nuti, C. Ulivieri, C.T. Baldari & S. Abrignani: T-cell costimulation by the hepatitis C virus envelope protein E2 binding to CD81 is mediated by Lck. Eur J Immunol 33, 455-464 (2003)
29. Mazzocca A., S.C. Sciammetta, V. Carloni, L. Cosmi, F. Annunziato, T. Harada, S. Abrignani & M. Pinzani: Binding of hepatitis C virus envelope protein E2 to CD81 up-regulates matrix metalloproteinase-2 in human hepatic stellate cells. J Biol Chem 280, 11329-11339 (2005)
30. Machida K., K.T. Cheng, N. Pavio, V.M. Sung & M.M.C. Lai: Hepatitis C virus E2-CD81 interaction induces hypermutation of the immunoglobulin gene in B cells. J Virol 79, 8079-8089 (2005)
31. Pöhlmann S., J. Zhang, F. Baribaud, Z. Chen, G.J. Leslie, G. Lin, A. Granelli-Piperno, R.W. Doms, C.M. Rice & J.A. McKeating: Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. J Virol 77, 4070-4080 (2003)
32. Lozach P.Y., A. Amara, B. Bartosch, J.L. Virelizier, F. Arenzana-Seisdedos, F.L. Cosset & R. Altmeyer: C-type lectins L-SIGN and DC-SIGN capture and transmit infectious hepatitis C virus pseudotype particles. J Biol Chem 279, 32035-32045 (2004)
33. Scarselli E., H. Ansuini, R. Cerino, R.M. Roccasecca, S. Acali, G. Filocamo, C. Traboni, A. Nicosia, R. Cortese & A. Vitelli: The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J 21, 5017-5025 (2002)
34. Voisset C., N. Callens, E. Blanchard, A. Op De Beeck, J. Dubuisson & N. Vu-Dac: High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type 1. J Biol Chem 280, 7793-7799 (2005)
35. Otto G.A. & J.D. Puglisi: The pathway of HCV IRES-mediated translation initiation. Cell 119, 369-380 (2004)
36. Ji H., C.S. Fraser, Y. Yu, J. Leary & J.A. Doudna: Coordinated assembly of human translation initiation complexes by the hepatitis C virus internal ribosome entry site RNA. Proc Natl Acad Sci USA 101, 16990-16995 (2004)
37. Cherry S., T. Doukas, S. Armknecht, S. Whelan, H. Wang, P. Sarnow & N. Perrimon: Genome-wide RNAi screen reveals a specific sensitivity of IRES-containing RNA viruses to host translation inhibition. Genes Dev. 19, 445-452 (2005)
38. Boni S., J.P. Lavergne, S. Boulant & A. Cahour: Hepatitis C virus cons protein acts as a trans-modulating factor on internal translation initiation of the viral RNA J Biol Chem 280, 17737-17748 (2005)
39. Kalliampakou K.I., M. Kalamvoki & P. Mavromara: Hepatitis C virus (HCV) NS5A protein downregulates HCV IRES-dependent translation. J Gen Virol 86, 1015-1025 (2005)
40. Gale M. Jr & E.M. Foy: Evasion of intracellular host defence by hepatitis C virus.Nature 436, 939-945 (2005)
41. Bovren D.G. & C.M. Walker Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 436, 946-952 (2005)
42. Rehermann B. & M. Nascimbeni: Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 5, 215-229 (2005)
43. Wieland S.F. & F.V. Chisari: Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol 79, 9369-9380 (2005)
44. Gremion C. & A. Cerny: Hepatitis C virus and the immune system: a concise review. Rev Med Virol 15, 235-268 (2005)
45. Sen G.C. & S.N. Sarkar: Transcriptional signaling by double-stranded RNA: role of TLR3. Cytokine Growth Factor Rev 16, 1-14 (2005)
46. Taylor D.R., S.T. Shi, P.R. Romano, G.N. Barber & M.M.C. Lai: Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 285, 107-110 (1999)
47. Gale M. Jr, M.J. Korth, N.M. Tang, S.L. Tan, D.A. Hopkins, T.E. Dever, S.J. Polyak, D.R. Gretch & M.G. Katze: Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 230, 217-227 (1997)
48. + T cells during persistent hepatitis C virus infection. J Virol 79, 7852-7859 (2005)
49. Yoneyama M., M. Kikuchi, T. Natsukawa, N. Shinobu, T. Imaizumi, M. Miyagishi, K. Taira, S. Akira & T. Fujita: The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5, 730-737 (2004)
50. Li K., E. Foy, J.C. Ferreon, M. Nakamura, A.C. Ferreon, M. Ikeda, S.C. Ray, M. Gale, Jr & S.M. Lemon: Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIP. Proc Natl Acad Sci USA 102, 2992-2997 (2005)
51. Otsuka M., N. Kato, M. Moriyama, H. Taniguchi, Y. Wang, N. Dharel, T. Kawabe & M. Omata: Interaction between the HCV NS3 protein and the host TBK1 protein leads to inhibition of cellular antiviral responses. Hepatology 41, 1004-1012 (2005)
52. Meylan E., J. Curran, K. Hofmann, D. Moradpour, M. Binder, R. Bartenschlager & J. Tschopp: Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437, 1167-1172 (2005)
53. Tardif K.D., G. Waris, & A. Siddiqui: Hepatitis C virus, ER stress, and oxidative stress. Trends Microbiol 13, 159-163 (2005)
54. Schroder M. & R.J. Kaufman: The mammalian unfolded protein response. Annu Rev Biochem 74, 739-789 (2005)
55. Tardif K.D., K. Mori & A. Siddiqui: Hepatitis C virus subgenomic replicons induce endoplasmic reticulum stress activating an intracellular signaling pathway. J Virol 76, 7453-7459 (2002)
56. Liberman E., Y.-L. Fong, M. J. Selby, Q.-L. Choo, L. Cousens, M. Houghton & T.S.B. Yen: Activation of the grp78 and grp94 promoters by hepatitis C virus E2 envelope protein. J Virol 73, 3718-3722 (1999)
57. Pavio N., P.R. Romano, T.M. Graczyk, S.M. Feinstone & D.R. Taylor: Protein synthesis and endoplasmic reticulum stress can be modulated by the hepatitis C virus envelope protein E2 through the eukaryotic initiation factor 2α kinase PERK. J Virol 77, 3578-3585 (2003)
58. Benali-Furet N.L., M. Chami, L. Houel, F. De Giorgi, F. Vernejoul, D. Lagorce, L. Buscail, R. Bartenschlager, F. Ichas, R. Rizzuto & P. Paterlini-Brechot: Hepatitis C virus core triggers apoptosis in liver cells by inducing ER stress and ER calcium depletion. Oncogene 24, 4921-4933 (2005)
59. Chan S.W. & P.A. Egan: Hepatitis C virus envelope proteins regulate CHOP via induction of the unfolded protein response. FASEB J 19, 1510-1512 (2005)
60. Tardif K.D., K. Mori, R.J. Kaufman & A. Siddiqui: Hepatitis C virus suppresses the IRE1-XBP1 pathway of the unfolded protein response. J Biol Chem 279, 17158-17164 (2004)
61. Tardif K.D. & A. Siddiqui: Cell surface expression of major histocompatibility complex class I molecules is reduced in hepatitis C virus subgenomic replicon-expressing cells. J Virol 77, 11644-11650 (2003)
62. Jopling C.L., M. Yi, A.M. Lancaster, S.M. Lemon & P. Samow: Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309, 1577-1581 (2005)
63. Humphreys D.T., B.J. Westman, D.I.K. Martin & T. Preiss: MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function. Proc Natl Acad Sci USA 102, 16961-16966 (2005)
64. Lohmann V., F. Korner, J. Koch, U. Herian, L. Theilmann & R. Bartenschlager: Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285, 110-113 (1999)
65. Bartenschlager R.: The hepatitis C virus replicon system: from basic research to clinical application. J Hepatol 43, 210-216 (2005)
66. Sumpter R. Jr., Y.M. Loo, E. Foy, K. Li, M. Yoneyama, T. Fujita, S.M. Lemon & M. Gale, Jr.: Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J Virol 79, 2689-2699 (2005)
67. Bukh J., T. Pietschmann, V. Lohmann, N. Krieger, K. Faulk, R.E. Engle, S. Govindarajan, M. Shapiro, M. St. Claire & R. Bartenschlager: Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees. Proc Natl Acad Sci USA 99, 14416-14421 (2002)
68. Butel J.S.: Viral carcino genesis: revelation of molecular mechanisms and etiology of human disease. Carcinagenesis 21, 405-426 (2000)
69. Pujol F. H. & M. Devesa: Genotypic variability of hepatitis viruses associated with chronic infection and the development of hepato cellular carcinoma. J Clin Gastoenterol 39, 611-618 (2005)
70. Fattovich G., T. Stroffolini, I. Zagni & F. Donato: Hepato cellular carcinoma in cirrhosis: incidence and risk factors. Gastro enterology 127, S35-S50 (2004)
71. Heathcote E.J.: Prevention of hepatitis C virus-related hepato cellular carcinoma. Gastro enterology 127, S294-S302 (2004)
72. El-Serag H.B.: Hepatocellular carcinoma: Recent trends in the United States. Castro enterology 127, S27-S34 (2004)
73. Leung N., C. Chu & J.S. Tam: Viral hepatitis C in Hong Kong. Intervirology 49, 23-27 (2006)
74. Yu M.C. & J.-M. Yuan: Environmental factors and risk for hepatocellular carcinoma. Gastroenterology 127, S72-S78 (2004)
75. Kato N., G. Ji, Y. Wang, M. Baba, Y. Hoshida, M. Otsuka, H. Taniguchi, M. Moriyama, N. Dharel, T. Goto, R.X. Shao, T. Matsuura, K. Ishii, S. Shiina, T. Kawabe, M. Muramatsu & M. Omata: Large-scale search of single nucleotide polymorphisms for hepatocellular carcinoma susceptibility genes in patients with hepatitis C.Hepatology 42, 846-853 (2005)
76. Karin M. & F.R. Greten: NF-κB: Linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5, 749-759 (2005)
77. Balkwill, F., K.A. Charles & A. Mantovani: Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7, 211-217 (2005)
78. Greten F.R., L. Eckmann, T.F. Greten, J.M. Park, Z.W. Li, L.J. Egan, M.F. Kagnoff & M. Karin: IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118, 285-296 (2004)
79. Aggarwal B.B.: Nuclear factor-κB: The enemy within. Cancer Cell 6, 203-208 (2004)
80. Pikarsky E., R.M. Porat, I. Stein, R. Abramovitch, S. Amit, S. Kasem, E. Gutkovich-Pyest, S. Uriell-Shoval, E. Galun & Y. Ben-Neriah: NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature 431, 4461-4466 (2004)
81. Lonardo A., L.E. Adinolfi, P. Loria, N. Carulli, G. Ruggiero & C.P. Day: Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease Gastroenterology 126, 586-597 (2004)
82. Patel K., A. Zekry & J.G. McHutchison: Steatosis and chronic hepatitis C virus infection: mechanisms and significance. Clin Liver Dis 9, 399-410 (2005)
83. Powell E.E, J.R Jonsson & A.D. Clouston: Steatosis: co-factor in other liver diseases. Hepatology 42, 5-13 (2005)
84. Moriya K., H. Yotsuyanagi, Y. Shintani, H. Fujie, K. Ishibashi, Y. Matsuura, T. Miyamura & K. Koike: Hepatitis C virus core protein induces hepatic Steatosis in transgenic mice. J Gen Virol 78, 1527-1531 (1997)
85. Barba G., F. Harper, T. Harada, M. Kohara, S. Goulinet, Y. Matsuuia, G. Eder, Z. Schaff, M.J. Chapman, T. Miyamura & C. Bréchot Hepatitis C virus core protein shows a cytopksmic localization and associates with cellular lipid storage droplets. Proc Natl Acad Sci USA 94, 1200-1205 (1997)
86. Ohata K., K. Hamasaki, K. Toriyama, K. Matsumoto, A. Saeki, K. Yanagi, S. Abiru, Y. Nakagawa, M. Shigeno, S. Miyazoe, T. Ichikawa, H. Ishikawa, K. Nakao & K. Eguchi: Hepatic Steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection. Cancer 97, 3036-3043 (2003)
87. Moriya K., K. Nakagawa, T. Santa, Y. Shintani, H. Fujie, H. Miyoshi, T. Tsutsumi, T. Miyazawa, K. Ishibashi, T. Hone, K. Imai, T. Todoroki, S. Kimura & K. Koike: Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res 61, 4365-4370 (2001)
88. Korenaga M., T. Wang, Y. Li, L.A. Showalter, T. Chan, J. Sun & S.A. Weinman: Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production. J Biol Chem 280, 37481-37488 (2005)
89. Schuppan D., A. Krebs, M. Bauer & E.G. Hahn: Hepatitis C and liver fibrosis. Cell Death Differ 10, S59-S67 (2003)
90. Gressner A.M., R. Weiskirchen, K. Breitkopf & S. Dooley: Roles of TGF-β in hepatic fibrosis. Front Biosci 7, d793-d807 (2002)
91. Powell E.E., C.J. Edwards-Smith, J.L. Hay, A.D. Clouston, D.H. Crawford, C. Shorthouse, D.M. Purdie & J.R. Jonsson: Host genetic factors influence disease progression in chronic hepatitis C. Hepatology 31, 828-833 (2000)
92. Beckman R.A. & L.A. Loeb: Genetic instability in cancer: theory and experiment. Semin Cancer Biol 15, 423-535 (2005)
93. Lengauer, C., K.W. Kinzler & B. Vogelstein: Genetic instabilities in human cancers. Nature 396, 643-649 (1998)
94. Machida K., K.T. Cheng, V.M. Sung, S. Shimodaira, K.L. Lindsay, A.M. Levine, M.Y. Lai & M.M.C. Lai: Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proc Natl Acad Sci USA 101, 4262-4267 (2004)
95. Machida K., K.T. Cheng, V.M. Sung, K.J. Lee, A.M. Levine & M.M.C. Lai: Hepatitis C virus infection activates the immunologic (type II) isoform of nitric oxide synthase and thereby enhances DNA damage and mutations of cellular genes. J Virol 78, 8835-8843 (2004)
96. Kawai H., T. Suda, Y. Aoyagi, O. Isokawa, Y. Mita, N. Waguri, T. Kuroiwa, M. Igarashi, K. Tsukada, S. Mori, T. Shimizu, Y. Suzuki, Y. Abe, T. Takahashi, M. Nomoto & H. Asakura: Quantitative evaluation of genomic instability as a possible predictor for development of hepatocellular carcinoma: comparison of loss of heterozygosity and replication error. Hepatology 31, 1246-1250 (2000)
97. Wong N., P. Lai, E. Pang, L.F. Fung, Z. Sheng, V. Wong, W. Wang, Y. Hayashi, E. Perlman, S. Yuna, J.W. Lau & P.J. Johnson: Genomic aberrations in human hepatocellular carcinomas of differing etiologies. Clin Cancer Res 6, 4000-4009 (2000)
98. Yang B., M. Guo, J.G. Herman & D.P. Clark: Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Am J Pathol 163, 1101-1107 (2003)
99. Tellinghuisen T.L. & CM. Rice: Interaction between hepatitis C virus proteins and host cell factors. Curr Opin Microbiol 5, 419-427 (2002)
100. Ray R.B. & R. Ray: Hepatitis C virus core protein: intriguing properties and functional relevance. FEMS Microbiol Let 202, 149-156 (2001)
101. Moriya K., H. Fujie, Y. Shintani, H. Yotsuyanagi, T. Tsutsumi, K. Ishibashi, Y. Matsuura, S. Kimura, T. Miyamura & K. Koike: The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med A, 1065-1067 (1998)
102. Lerat H., M. Honda, M.R. Beard, K. Loesch, J. Sun, Y. Yang, M. Okuda, R. Gosert, S.Y. Xiao, S.A. Weinman & S.M. Lemon: Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterology 122, 352-365 (2002)
103. Jin D.Y., H.L. Wang, Y. Zhou, A.C.S. Chun, K.V. Kibler, Y.D. Hou, H. Kung & K.T. Jeang: Hepatitis C virus core protein-induced loss of LZIP function correlates with cellular transformation. EMBO J. 19, 729-740 (2000)
104. Kang S.M., M.J. Shin, J.H. Kim & J.W. Oh: Proteomic profiling of cellular proteins interacting with the hepatitis C virus core protein. Proteomics 5, 2227-2237 (2005)
105. Chin K.T., H.J. Zhou, C.M. Wong, J.M.F. Lee, C.P. Chan, B.Q. Qiang, J.G. Yuan, I.O.L. Ng & D.Y. Jin: The liver-enriched transcription factor CREB-H is a growth suppressor protein underexpressed in hepatocellular carcinoma. Nucl Acids Res 33, 1859-1873 (2005)
106. Munakata T., M. Nakamura, Y. Liang, K. Li & S.M. Lemon: Down-regulation of the retinoblastoma tumor suppressor by the hepatitis C virus NS5B RNA-dependent RNA polymerase. Proc Natl Acad Sci USA 102, 18159-18164 (2005)
107. Street A., A. Macdonald, C. McCormick & M. Harris: Hepatitis C virus NS5A-mediated activation of phosphoinositide 3-kinase results in stabilization of cellular β-catenin and stimulation of β-catenin-responsive transcription. J Virol 79, 5006-5016 (2005)